SCHEMBL3987306

SCHEMBL3987306

[CH2]c1nnc(N)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL272220 0.75
SCHEMBL6002352 0.67 NOTUM (0.56)
SCHEMBL470129 0.62
SCHEMBL957412 0.62
SCHEMBL7045744 0.62
SCHEMBL5175494 0.62
SCHEMBL508672 0.62
SCHEMBL2868023 0.62
SCHEMBL18571212 0.62
SCHEMBL17153742 0.61 NOTUM (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090291921-A1 INTEGRASE INHIBITORS GILEAD SCIENCES, INC. (US) 2009-11-26 US claimed
WO-2009067541-A2 INTEGRASE INHIBITORS GILEAD SCIENCES, INC. (US) 2009-05-28 WO claimed
EP-2712315-B1 LYSINE DEMETHYLASE INHIBITORS FOR MYELOPROLIFERATIVE DISORDERS ORYZON GENOMICS SA (ES) 2021-11-24 EP disclosed
US-9908859-B2 Lysine demethylase inhibitors for myeloproliferative disorders ORYZON GENOMICS, S.A. (ES) 2018-03-06 US disclosed
US-9790196-B2 Lysine demethylase inhibitors for diseases and disorders associated with Flaviviridae ORYZON GENOMICS S.A. (ES) 2017-10-17 US disclosed
US-20170209432-A1 LYSINE DEMETHYLASE INHIBITORS FOR MYELOPROLIFERATIVE OR LYMPHOPROLIFERATIVE DISEASES OR DISORDERS ORYZON GENOMICS SA (ES) 2017-07-27 US disclosed
US-20160081947-A1 SELECTIVE LSD1 AND DUAL LSD1/MAO-B INHIBITORS FOR MODULATING DISEASES ASSOCIATED WITH ALTERATIONS IN PROTEIN CONFORMATION ORYZON GENOMICS S.A. (ES) 2016-03-24 US disclosed
US-20150232436-A1 LYSINE DEMETHYLASE INHIBITORS FOR MYELOPROLIFERATIVE DISORDERS ORYZON GENOMICS S.A. (ES) 2015-08-20 US disclosed
US-20140329833-A1 LYSINE DEMETHYLASE INHIBITORS FOR INFLAMMATORY DISEASES OR CONDITIONS ORYZON GENOMICS, S.A (ES) 2014-11-06 US disclosed
US-20140296255-A1 LYSINE DEMETHYLASE INHIBITORS FOR THROMBOSIS AND CARDIOVASCULAR DISEASES ORYZONG GENOMICS, S.A. (ES) 2014-10-02 US disclosed
US-20140256742-A1 LYSINE DEMETHYLASE INHIBITORS FOR DISEASES AND DISORDERS ASSOCIATED WITH FLAVIVIRIDAE ORYZON GENOMICS S.A. (ES) 2014-09-11 US disclosed
WO-2009067541-A2 INTEGRASE INHIBITORS GILEAD SCIENCES, INC. (US) 2009-05-28 WO disclosed
US-7276517-B2 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase ASTRAZENECA AB (SE) 2007-10-02 US disclosed
US-20070043069-A1 3-Amino-3,4-dihydro-1,5-naphthyridin-2(1H)-one and its dihydrochloride; intermediates for producing naphthyridinylaminocarbonyl-substituted pyrrolothiopyrans and imidazolothiopyrans ASTRAZENECA AB (SE) 2007-02-22 US disclosed
US-7169927-B2 Indole-amide derivatives and their use as glycogen phosphorylase inhibitors ASTRAZENECA AB (SE) 2007-01-30 US disclosed
US-7129249-B2 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase ASTRAZENECA AB (SE) 2006-10-31 US disclosed
US-20050131016-A1 Chemical compounds ASTRAZENECA AB (SE) 2005-06-16 US disclosed
US-20050131015-A1 Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase ASTRAZENECA AB (SE) 2005-06-16 US disclosed
EP-1480516-A1 MICROBICIDAL AGENTS ON THE BASIS OF BIPHENYL BENZAMIDE DERIVATIVES Bayer CropScience AG (DE) 2004-12-01 EP disclosed
WO-2003069995-A1 MICROBICIDAL AGENTS ON THE BASIS OF BIPHENYL BENZAMIDE DERIVATIVES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2003-08-28 WO disclosed